Phytosterols and the Digestive System: A Review Study from Insights into Their Potential Health Benefits and Safety

Edyta Miszczuk,Andrzej Bajguz,Łukasz Kiraga,Kijan Crowley,Magdalena Chłopecka

DOI: https://doi.org/10.3390/ph17050557

IF: 4.6

2024-04-27

Pharmaceuticals

Abstract:Phytosterols are a large group of substances belonging to sterols—compounds naturally occurring in the tissues of plants, animals, and humans. The most well-known animal sterol is cholesterol. Among phytosterols, the most significant compounds are β-sitosterol, stigmasterol, and campesterol. At present, they are mainly employed in functional food products designed to counteract cardiovascular disorders by lowering levels of 'bad' cholesterol, which stands as their most extensively studied purpose. It is currently understood that phytosterols may also alleviate conditions associated with the gastrointestinal system. Their beneficial pharmacological properties in relation to gastrointestinal tract include anti-inflammatory and hepatoprotective activity. Also, the anti-cancer properties as well as the impact on the gut microbiome could be a very interesting area of research, which might potentially lead to the discovery of their new application. This article provides consolidated knowledge on a new potential use of phytosterols, namely the treatment or prevention of gastrointestinal diseases. The cited studies indicate high therapeutic efficacy in conditions such as peptic ulcer disease, IBD or liver failure caused by hepatotoxic xenobiotics, however, these are mainly in vitro or in vivo studies. Nevertheless, studies to date indicate their therapeutic potential as adjunctive treatments to conventional therapies, which often exhibit unsatisfactory efficacy or serious side effects. Unfortunately, at this point there is a lack of significant clinical study data to use phytosterols in clinical practice in this area.

pharmacology & pharmacy,chemistry, medicinal

What problem does this paper attempt to address?

The paper aims to explore the effects of phytosterols on the digestive system (including the gastrointestinal tract and its accessory organs such as the liver) and to assess their potential as an adjunct to traditional treatments. Specifically, the paper attempts to address the following key issues:

1. **Potential Benefits of Phytosterols for Gastrointestinal Diseases**: Investigate the role of phytosterols in gastrointestinal diseases, particularly their anti-inflammatory and hepatoprotective properties. These diseases include gastric ulcers, inflammatory bowel disease (IBD), and others.

2. **Mechanisms of Anti-inflammatory and Hepatoprotective Actions of Phytosterols**: Discuss in detail how phytosterols reduce inflammatory responses by inhibiting the COX-2 enzyme without affecting the protective COX-1 enzyme. Additionally, phytosterols can reduce oxidative stress and protect the gastric mucosa from damage.

3. **Application of Phytosterols in Non-Alcoholic Fatty Liver Disease (NAFLD)**: The paper discusses the potential role of phytosterols in the treatment of NAFLD, particularly in reducing inflammation and oxidative stress. NAFLD is a common chronic liver disease associated with factors such as obesity and diabetes.

4. **Safety and Clinical Application Prospects of Phytosterols**: Although many studies show significant health benefits of phytosterols, there is currently a lack of sufficient clinical data to support their widespread use in the treatment of digestive system diseases. Therefore, the paper emphasizes the importance of further clinical trials.

In summary, this paper aims to synthesize existing research to evaluate the potential of phytosterols in the prevention and treatment of gastrointestinal diseases and to explore their possible clinical applications.